CN
63-99-0
应用筛选条件
关键词:'63-99-0'
显示 1-30 共 160 条结果 关于 "63-99-0" 范围 技术文档
The Effective Use of Protein Kinase Inhibitors
82 61
48 75 38 99 86 8 6 54 66 10 83 105 106 103
99 98 103 104 101 67 95 77 101 95 82 99 67 96 90 76 93 63 98 105 83 69
The Effective Use of Protein Kinase Inhibitors
82 61
48 75 38 99 86 8 6 54 66 10 83 105 106 103
99 98 103 104 101 67 95 77 101 95 82 99 67 96 90 76 93 63 98 105 83 69
Bulletin - 710332C
chloroform solution
Purity > 99% Transition temp. No data
CAS 63988-20-5 CMC No data
Synonyms 1,1’,2,2’ Tetramyristoyl Cardiolipin;
CL(1’-[14:0/14:0],3’-[14:0/14:0]);
14:0 CA
PKA No data
Molec.
Bulletin - 710332P
chloroform solution
Purity > 99% Transition temp. No data
CAS 63988-20-5 CMC No data
Synonyms 1,1’,2,2’ Tetramyristoyl Cardiolipin;
CL(1’-[14:0/14:0],3’-[14:0/14:0]);
14:0 CA
PKA No data
Molec.
Data Sheet - F1884 - Lot 111K8811
40 60 80 100 120 140 160 180 200 220
0
50000
100000
150000
200000
250000
300000
350000
m/z
Abundance
44
56 63
72
89 99
109
119
Data Sheet - C1037 - Lot 22K8805F
Ionization Mass Spectrum
40 60 80 100 120 140 160 180 200 220 240
0
10000
20000
30000
40000
50000
m/z
Abundance
44
51 63 75 89 95 115 128
139 152
Data Sheet - A2794
30 40 50 60 70 80 90 100 110 120 130 140 150
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
m/z
Abundance
43
53
63 68
Data Sheet - C1037 - Lot 22K8805
Mass Spectrum
40 60 80 100 120 140 160 180 200 220 240
0
10000
20000
30000
40000
50000
m/z
Abundance
44
51 63 75 89 95 115 128
Data Sheet - C0430 - Lot 015K8801
Ionization Mass Spectrum
m/z
Abundance
42 51 63 69 78
98
99
118
121
133
147
161
176
177
40 60 80 100 120 140 160 180
0
10000
Data Sheet - A8535
110 120 130 140 150 160 170 180 190 200 210 220 230
0
5000
10000
15000
20000
25000
30000
35000
m/z
Abundance
42
58
63 77 91 101
Data Sheet - F8763
80 100 120 140 160 180 200 220 240 260 280 300
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
m/z
Abundance
42 51
63 75 91
Data Sheet - D7782
diluted in normal
human serum to obtain standard solutions at the
following concentrations: 125, 63, 31 and 15
pg/0.1ml.
(B) Phosphate Buffered Saline, 0.01M, pH 7.4,
containing 0.1% sodium azide
Bulletin - 750332C
Number 750332 Physical state Powder; chloroform solution
Purity > 99% Transition temp. No data
CAS 63988-21-6 CMC No data
Synonyms 14:0 CA PKA No data
Molec. Formula C65H124O17P2Na2 TLC mobile phase C:M
Bulletin - 750332P
Number 750332 Physical state Powder; chloroform solution
Purity > 99% Transition temp. No data
CAS 63988-21-6 CMC No data
Synonyms 14:0 CA PKA No data
Molec. Formula C65H124O17P2Na2 TLC mobile phase C:M
Product Information Sheet - A4327
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A1887
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A2817
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A9080
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A3782
A 1653 Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817 Fraction V1 Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced specifically
Product Information Sheet - A6784
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A9511
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A8763
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A3173
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A1653
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Product Information Sheet - A6909
Fraction V1
From human serum.
Powder
96-99% by agarose gel
(remainder mostly globulins)
A 2817
Fraction V1
Powder
96-99% by agarose gel
(remainder mostly globulins)
Produced
Reagents
, thus minimizing the total volume to be centrifuged
for DNA or RNA recovery.
Water: ≤0.05%
[67-63-0] C3H8O FW 60.10
Reference
1. Sambrook, J., et al., Molecular Cloning: A Laboratory Manual
Data Sheet - D3062
diluted in buffer (B) to
obtain standard solutions at the following
concentrations: 500, 250, 125, 63, 31, 15, 8, and
4 pg/0.1 ml.
(B) Dilution buffer: 0.05 M
Data Sheet - P5164
diluted in buffer (B) to obtain
standard solutions at the following concentrations:
500, 250, 125, 63, 31, and
15 pg/0.1 ml.
(B) Dilution buffer: 0.01 M phosphate buffered saline,
pH 7.4 containing
Publication Microbiology: An evaluation of a new chromogenic / flourogenic microbiology media system
Coliforms E. coli
EPA 91 63 90 62 1 b
Impurities & Related Compounds: Reference Materials
123-91-1
71-36-3
71-36-3
71-41-0
71-23-8
78-92-2
110-80-5
109-86-4
78-83-1
67-63-0
67-63-0
123-51-3
75-07-0
75-07-0
64-19-7
67-64-1
67-64-1
75-05-8
1/6